Literature DB >> 29923171

Comment on "Population Pharmacokinetics of Mycophenolic Acid: An Update".

Jean-Baptiste Woillard1,2,3, Jean Debord4,5,6, Pierre Marquet4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29923171     DOI： 10.1007/s40262-018-0687-9

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  17 in total

1.  Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome.

Authors:  F Saint-Marcoux; V Guigonis; S Decramer; P Gandia; B Ranchin; F Parant; L Bessenay; F Libert; J Harambat; S Bouchet; F Broux; P Compagnon; P Marquet
Journal:  Pharmacol Res       Date:  2011-01-25       Impact factor: 7.658

2.  Application of a gamma model of absorption to oral cyclosporin.

Authors:  J Debord; E Risco; M Harel; Y Le Meur; M Büchler; G Lachâtre; C Le Guellec; P Marquet
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods.

Authors:  Aurélie Prémaud; Yannick Le Meur; Jean Debord; Jean-Christophe Szelag; Annick Rousseau; Guillaume Hoizey; Olivier Toupance; Pierre Marquet
Journal:  Ther Drug Monit       Date:  2005-06       Impact factor: 3.681

Review 4.  Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 5.  Therapeutic drug monitoring of mycophenolic acid.

Authors:  Leslie M Shaw; Michal Figurski; Michael C Milone; Jennifer Trofe; Roy D Bloom
Journal:  Clin J Am Soc Nephrol       Date:  2007-08-16       Impact factor: 8.237

6.  A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients.

Authors:  Nicolas Picard; Aurélie Prémaud; Annick Rousseau; Yannick Le Meur; Pierre Marquet
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

7.  Mycophenolic mofetil optimized pharmacokinetic modelling, and exposure-effect associations in adult heart transplant recipients.

Authors:  Jean-Baptiste Woillard; Franck Saint-Marcoux; Caroline Monchaud; Rym Youdarène; Lucie Pouche; Pierre Marquet
Journal:  Pharmacol Res       Date:  2015-07-17       Impact factor: 7.658

8.  Mycophenolic acid 12-hour area under the curve in de novo liver transplant patients given mycophenolate mofetil at fixed versus concentration-controlled doses.

Authors:  Nassim Kamar; Pierre Marquet; Peggy Gandia; Fabrice Muscari; Laurence Lavayssière; Laure Esposito; Joelle Guitard; Cindy Canivet; Jean Marie Peron; Laurent Alric; Bertrand Suc; Franck Saint-Marcoux; Lionel Rostaing
Journal:  Ther Drug Monit       Date:  2009-08       Impact factor: 3.681

9.  Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.

Authors:  Flora T Musuamba; Annick Rousseau; Jean-Louis Bosmans; Jean-Jacques Senessael; Jean Cumps; Pierre Marquet; Pierre Wallemacq; Roger K Verbeeck
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

10.  Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring.

Authors:  Jean-Baptiste Woillard; Brigitte Bader-Meunier; Rémi Salomon; Bruno Ranchin; Stéphane Decramer; Michel Fischbach; Etienne Berard; Vincent Guigonis; Jérôme Harambat; Olivier Dunand; Julie Tenenbaum; Pierre Marquet; Franck Saint-Marcoux
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335
View more
  2 in total

1.  Population pharmacokinetics and Bayesian estimators for intravenous mycophenolate mofetil in haematopoietic stem cell transplant patients.

Authors:  Marc Labriffe; Julien Vaidie; Caroline Monchaud; Jean Debord; Pascal Turlure; Stephane Girault; Pierre Marquet; Jean-Baptiste Woillard
Journal:  Br J Clin Pharmacol       Date:  2020-02-28       Impact factor: 4.335

2.  Author's Reply to Woillard et al.: "Population Pharmacokinetics of Mycophenolic Acid: an Update".

Authors:  Tony K L Kiang; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.